Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation

PURPOSE: The German Hodgkin Study Group HD11 trial validated 4 cycles of doxorubicin, bleomycin, vinblastine, dacarbazine (ABVD) chemotherapy followed by involved field radiation therapy (IFRT) for early unfavorable Hodgkin lymphoma (HL) patients. However, practitioners often recommend 6 cycles foll...

Full description

Saved in:
Bibliographic Details
Published in:Int J Radiat Oncol Biol Phys
Main Authors: Gunther, Jillian R., Fanale, Michelle A., Reddy, Jay P., Akhtari, Mani, Smith, Grace L., Pinnix, Chelsea C., Milgrom, Sarah A., Yehia, Zeinab Abou, Allen, Pamela K., Osborne, Eleanor M., Mawlawi, Osama, Dabaja, Bouthaina S.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6047754/
https://ncbi.nlm.nih.gov/pubmed/27325479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2016.03.052
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items